UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
Acta neuropathologica, ISSN 0001-6322, 5/2011, Volume 121, Issue 5, pp. 597 - 609
Interlaboratory study | Pathology | Neurosciences | Medicine & Public Health | Cerebrospinal fluid | p-tau 181 | Amyloid-β1-42 | Total tau | Alzheimer’s Disease Neuroimaging Initiative | Mixed-effects modeling | Alzheimer's Disease Neuroimaging Initiative | p-tau | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Reproducibility of Results | Peptide Fragments - cerebrospinal fluid | Prognosis | Humans | Middle Aged | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Alzheimer Disease - mortality | Sensitivity and Specificity | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Aged | Cognitive Dysfunction - diagnosis | Biomarkers - cerebrospinal fluid | Cognitive Dysfunction - mortality | Index Medicus | p-tau181 | Psykiatri | Psychiatry
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2014, Volume 41, Issue 2, pp. 441 - 451
mass spectrometry | Alzheimer's disease | cerebrospinal fluid | amyloid-$\beta_{42} | Immunoassay | Peptide Fragments - cerebrospinal fluid | Guanidine - chemistry | Humans | Middle Aged | Linear Models | Calibration | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Acetonitriles - chemistry | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Chromatography, Liquid | Adult | ROC Curve | Aged | Biomarkers - cerebrospinal fluid | Tandem Mass Spectrometry - methods | Quality Control | Index Medicus | Alzheimer’s disease | amyloid-β42
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 12/2020, Volume 16, p. n/a
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2019, Volume 15, pp. P1022 - P1022
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2019, Volume 15, pp. P341 - P341
Journal Article
6.
Full Text
P2‐091: ASSAY PERFORMANCE MONITORING FOR AD BIOMARKERS USING POOLED CEREBROSPINAL FLUID
Alzheimer's & dementia, ISSN 1552-5260, 07/2018, Volume 14, Issue 7S_Part_13, pp. P702 - P703
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P1317 - P1318
Journal Article
Acta neuropathologica, ISSN 0001-6322, 10/2011, Volume 122, Issue 4, pp. 401 - 413
Pathology | Neurosciences | Biomarker | Prognosis | Medicine & Public Health | Alzheimer disease | Amyloid beta-peptides | Diagnosis | Cerebrospinal fluid | PET | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging - methods | Brain Infarction - diagnosis | Prospective Studies | Humans | Middle Aged | Brain Infarction - metabolism | Male | Biomarkers - blood | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Magnetic Resonance Imaging | Brain Infarction - blood | Alzheimer Disease - metabolism | Aged, 80 and over | Female | Aged | Longitudinal Studies | Alzheimer Disease - blood | Cohort Studies | Index Medicus | Neurodegenerative diseases | biomarkers | Cognitive ability | beta -Amyloid | Magnetic resonance imaging | Tau protein | Classification | Infarction | Plasma levels | Alzheimer's disease | Positron emission tomography | Age
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2018, Volume 14, Issue 7S_Part_7, pp. P378 - P378
Journal Article
Alzheimer's & dementia : diagnosis, assessment & disease monitoring, ISSN 2352-8729, 2018, Volume 10, Issue 1, pp. 698 - 705
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 2015, Volume 11, Issue 7, pp. P386 - P387
Journal Article
Therapeutic drug monitoring, ISSN 0163-4356, 12/2009, Volume 31, Issue 6, pp. 717 - 726
LC-MS/MS | Mycophenolic acid | Metabolites | Free concentration | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Limit of Detection | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Microchemistry - methods | Humans | Immunosuppressive Agents - pharmacokinetics | Mycophenolic Acid - urine | Mycophenolic Acid - pharmacokinetics | Glucuronides - urine | Calibration | Glucuronides - blood | Immunosuppressive Agents - urine | Glucuronides - metabolism | Immunosuppressive Agents - blood | Mycophenolic Acid - analogs & derivatives | Spectrometry, Mass, Electrospray Ionization | Time Factors | Mycophenolic Acid - blood | Analytic Sample Preparation Methods | Tandem Mass Spectrometry - methods | Acylation | Plasma | Immunotherapy | Pharmacology | Drug therapy | Mass spectrometry | Chromatography | Index Medicus
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7S_Part_8, pp. P386 - P387
Journal Article
The journal of applied laboratory medicine, ISSN 2576-9456, 01/2020, Volume 5, Issue 1, pp. 183 - 193
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2012, Volume 8, Issue 4, pp. 250 - 260
Neurology | Plasma | xMAP immunoassay | Longitudinal | Robotic pipetting | ADNI study subjects | β-amyloid | β‐amyloid | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging | Immunoassay | Peptide Fragments - cerebrospinal fluid | Humans | Male | Statistics as Topic | Alzheimer Disease - cerebrospinal fluid | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Likelihood Functions | Peptide Fragments - blood | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Aged | Longitudinal Studies | Alzheimer Disease - blood | Index Medicus
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7, pp. 772 - 791
Neurology | ADNI | Plasma | Immunoassay | Mild cognitive impairment | Biomarkers | Tau | Cerebrospinal fluid | Alzheimer's disease | Disease-modifying therapy | Aβ1–42 | Disease‐modifying therapy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - diagnosis | Databases, Bibliographic - statistics & numerical data | Peptide Fragments - cerebrospinal fluid | Humans | Amyloid beta-Peptides - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Medical colleges | Development and progression | Neurosciences | Diagnostic imaging | Index Medicus | Alzheimer’s disease | Neurologi | CSF BIOMARKERS | APOLIPOPROTEIN-E GENOTYPE | TANDEM MASS-SPECTROMETRY | CEREBROSPINAL-FLUID BIOMARKERS | AMYLOID-BETA | A-BETA | DIAGNOSTIC GUIDELINES | GENOME-WIDE ASSOCIATION
Journal Article